MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of October 28, 2026, MXCT trades at $1.64 with a market cap of $155.84M and a P/E ratio of -2.54. MXCT moved +5.52% today. Year to date, MXCT is -0.65%; over the trailing twelve months it is +0.00%. Its 52-week range spans $0.64 to $3.58. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MXCT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.64 |
| Market Cap | $155.84M |
| P/E Ratio | -2.54 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.58 |
| 52-Week Low | $0.64 |
| Volume | 189.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $33.03M |
| Net Income | $-44.63M |
| Gross Margin | 81.16% |
3 analysts cover MXCT: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.